South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "CHILL-SSC" on Aug. 22. The details about the trademark application no. UK00004253342 published in the journal no. 2025/036 (Sept. 5).
With Dehns as representative, Quell Therapeutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Chemical and biological preparations for use in science and industry; chemical and biological preparations for non-medical purposes; preparations for genetically modifying human and animal cells [other than for medical or veterinary purposes]; reagents for use in the genetic modification of human and animal calls [other than for medical or veterinary purposes]; human and animal cells and parts thereof for scientific and research purposes; T cells for scientific and research purposes; regulatory T cells for scientific and research purposes; preparations of blood or cells extracted from humans and animals for scientific and research purposes; immunological agents and preparations for non-medical purposes; chimeric antigen receptors and preparations thereof for scientific and research purposes; antibody reagents for use in science and industry; nucleic acids; nucleic recombinant acids; synthetic deoxyribonucleic acids; viral vectors for use in science and industry; nucleic acid vectors for use in science and industry.
Class 5 : Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use; pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes; preparations for cell therapy; preparations for gene therapy; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; human and animal cells and parts thereof for medical and veterinary purposes; T cells for medical and veterinary purposes; regulatory T cells for medical and veterinary purposes; preparations of blood or cells extracted from humans and animals which have been adapted for therapeutic purposes; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; immunological agents and preparations for medical purposes; preparations for therapies to modulate the immune system; preparations for therapies for autoimmune conditions and immunological disorders; chimeric antigen receptors and therapeutic preparations thereof; antibodies; preparations for therapeutic delivery of nucleic acids; viral vectors for therapeutic and prophylactic purposes; nucleic acid vectors for therapeutic and prophylactic purposes; medical preparations containing viral vectors for therapeutic and prophylactic purposes; medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes.
Class 40 : Pharmaceutical manufacturing and processing; biological, biotechnological and biopharmaceutical manufacturing and processing; biological tissue, blood, cell and genetic material processing; viral vector production and manufacture; gene therapy production and manufacture; custom manufacture of pharmaceutical and biological formulations and products; processing and modification of human and animal cells in the custom manufacture of pharmaceutical and biological formulations and products.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004253342
Disclaimer: Curated by HT Syndication.
